Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

CytoMed Therapeutics Ltd (GDTC)

1,29

0,11

(9,32%)

Geschlossen 08 Juni 10:00PM

1,29

0,00

(0,00%)

Nach Börsenschluss: 1:30AM

Professionelle Tools für Privatanleger.

Premium

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 144 - Report of proposed sale of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 144 - Report of proposed sale of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Foren

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

CytoMed Therapeutics

Ares Lusitani Domestic b...

Doubleline Asset backed ...

Elix Rental Housing Soci...

1.183% until 16apr2050 1...

Gold Miners Screened UCI...

European Biotech Acquisi...

Interest Rate Linked Not...

Western Asset Mortgage O...

2.5329% Index Linked Bon...

Invesco Markets

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

ADVFN

Haben Sie schon ein Konto? Anmelden

Haben Sie kein Konto? Registrieren

Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.